# Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/alteration-of-pd-l1-expression-and-its-prognostic-impact-after-concurrent/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daichi Fujimoto,Keiichiro Uehara,Yuki Sato,Ichiro Sakanoue,Munehiro Ito,Shunsuke Teraoka,Kazuma Nagata,Atsushi Nakagawa,Yasuhiro Kosaka,Kojiro Otsuka,Yukihiro Imai,Hiroshi Hamakawa,Yutaka Takahashi,Masaki Kokubo,Keisuke Tomii |
| Citations | 87 |
| DOI | 10.1038/s41598-017-11949-9 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41598-017-11949-9.pdf |
| OpenAlex ID | https://openalex.org/W2750913206 |
| PMID | 28900290 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Daichi Fujimoto](https://scholariq.org/researchers/daichi-fujimoto/)

## Paper journal

- [Scientific Reports](https://scholariq.org/journals/scientific-reports/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.